Scottish BioTech raises funds to make cancer therapies accessible

Edinburgh-based BioTech Lentitek Ltd has secured £700,000 in private funding to make cancer therapies more widely accessible. The funding comes from Equity Gap, a leading Scottish angel investment syndicate, bringing its total investment to £1m in the last six months after the firm received a £300,000 Innovate UK grant.  It will be used to accelerate … Continue reading Scottish BioTech raises funds to make cancer therapies accessible